The role of nurses and APPs is crucial to ensuring patients with cancer can receive newer therapies, shares David A. Braun, MD, PhD.
David A. Braun, MD, PhD
Advertisement
David A. Braun, MD, PhD, is an assistant professor at Yale School of Medicine and principal investigator in the Center of Molecular and Cellular Oncology within the Yale Cancer Center.
Articles by David A. Braun, MD, PhD
David A. Braun, MD, PhD, explained that personalized cancer vaccines can be associated with toxicities typical of both vaccines and immunotherapies.
Advertisement
Latest Updated Articles
"It's a Team-Based Approach": Nurses in Trial EnrollmentPublished: September 23rd 2025 | Updated:
Personalized Cancer Vaccines: Watching For Immune-Related, Vaccine AEsPublished: August 18th 2025 | Updated:
Advertisement
Advertisement
